Review





Similar Products

96
Santa Cruz Biotechnology p16
Immunohistochemical analysis of <t>p16</t> and p21 in liver tissue. (A, B) Representative immunohistochemistry images of (A) p16 and (B) p21 staining in DBD and DCD liver tissue sections. Scale bars represent 250 μm. (C, D) Quantification of (C) p16‐positive and (D) p21‐positive stained nuclei in DBD and DCD. (E, F) Expression of (E) CDKN2A (p16 INK4a /p19 ARF ) and (F) CDKN1A (p21 CIP1 ) in DBD and DCD, with a higher expression of CDKN2A (p16 INK4a /p19 ARF ) in DCD grafts ( p = 0.229) and an upregulation of CDKN1A (p21 CIP1 ) in DBD grafts ( p < 0.001). DBD; donation after brain death, DCD; donation after circulatory death.
P16, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+p16/p16/pmc13755069-82-12-16
Average 96 stars, based on 1 article reviews
p16 - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

96
Proteintech rabbit anti human p16 ink4a
Immunohistochemical analysis of <t>p16</t> and p21 in liver tissue. (A, B) Representative immunohistochemistry images of (A) p16 and (B) p21 staining in DBD and DCD liver tissue sections. Scale bars represent 250 μm. (C, D) Quantification of (C) p16‐positive and (D) p21‐positive stained nuclei in DBD and DCD. (E, F) Expression of (E) CDKN2A (p16 INK4a /p19 ARF ) and (F) CDKN1A (p21 CIP1 ) in DBD and DCD, with a higher expression of CDKN2A (p16 INK4a /p19 ARF ) in DCD grafts ( p = 0.229) and an upregulation of CDKN1A (p21 CIP1 ) in DBD grafts ( p < 0.001). DBD; donation after brain death, DCD; donation after circulatory death.
Rabbit Anti Human P16 Ink4a, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+p16/P16-INK4A+Antibody/pm42994431-299-96-99
Average 96 stars, based on 1 article reviews
rabbit anti human p16 ink4a - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

96
Proteintech p16
Immunohistochemical analysis of <t>p16</t> and p21 in liver tissue. (A, B) Representative immunohistochemistry images of (A) p16 and (B) p21 staining in DBD and DCD liver tissue sections. Scale bars represent 250 μm. (C, D) Quantification of (C) p16‐positive and (D) p21‐positive stained nuclei in DBD and DCD. (E, F) Expression of (E) CDKN2A (p16 INK4a /p19 ARF ) and (F) CDKN1A (p21 CIP1 ) in DBD and DCD, with a higher expression of CDKN2A (p16 INK4a /p19 ARF ) in DCD grafts ( p = 0.229) and an upregulation of CDKN1A (p21 CIP1 ) in DBD grafts ( p < 0.001). DBD; donation after brain death, DCD; donation after circulatory death.
P16, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+p16/P16-INK4A+Antibody/pm42989047-205-64-71
Average 96 stars, based on 1 article reviews
p16 - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

96
Proteintech anti p16 ink4a
Ramelteon inhibits astrocytic senescence and alleviates DA neurodegeneration in MPTP-induced PD mouse model. (A) Representative images of TH immunohistochemical staining in the SNc of mice from the indicated groups. n = 6. Scale bar, 100 μm. (B) Quantification of TH + neuron numbers in the SNc. (C) Rotarod test latency to fall. n = 8. (D) Pole test descending time. n = 8. (E) Immunoblot analysis of <t>p16</t> <t>Ink4a</t> , LaminB1, and β-actin in SNc tissues. n = 3. (F) qRT-PCR analysis of IL-6 , IL-1β , CXCL10 , and MMP9 mRNA levels in the midbrain. n = 3. Data are presented as mean ± SEM. *p < 0 .05 , **p < 0.01 ; ns, not significant. One-way ANOVA followed by Tukey’s post-hoc test.
Anti P16 Ink4a, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+p16/P16-INK4A+Antibody/pmc13745544-94-3-6
Average 96 stars, based on 1 article reviews
anti p16 ink4a - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

96
Rockland Immunochemicals red fluorescent protein rfp
Ramelteon inhibits astrocytic senescence and alleviates DA neurodegeneration in MPTP-induced PD mouse model. (A) Representative images of TH immunohistochemical staining in the SNc of mice from the indicated groups. n = 6. Scale bar, 100 μm. (B) Quantification of TH + neuron numbers in the SNc. (C) Rotarod test latency to fall. n = 8. (D) Pole test descending time. n = 8. (E) Immunoblot analysis of <t>p16</t> <t>Ink4a</t> , LaminB1, and β-actin in SNc tissues. n = 3. (F) qRT-PCR analysis of IL-6 , IL-1β , CXCL10 , and MMP9 mRNA levels in the midbrain. n = 3. Data are presented as mean ± SEM. *p < 0 .05 , **p < 0.01 ; ns, not significant. One-way ANOVA followed by Tukey’s post-hoc test.
Red Fluorescent Protein Rfp, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+p16/Anti-mCherry+Antibody+Pre-Adsorbed/pmc13757097-39-0-17
Average 96 stars, based on 1 article reviews
red fluorescent protein rfp - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

96
Proteintech polyclonal anti p16 antibody
Ramelteon inhibits astrocytic senescence and alleviates DA neurodegeneration in MPTP-induced PD mouse model. (A) Representative images of TH immunohistochemical staining in the SNc of mice from the indicated groups. n = 6. Scale bar, 100 μm. (B) Quantification of TH + neuron numbers in the SNc. (C) Rotarod test latency to fall. n = 8. (D) Pole test descending time. n = 8. (E) Immunoblot analysis of <t>p16</t> <t>Ink4a</t> , LaminB1, and β-actin in SNc tissues. n = 3. (F) qRT-PCR analysis of IL-6 , IL-1β , CXCL10 , and MMP9 mRNA levels in the midbrain. n = 3. Data are presented as mean ± SEM. *p < 0 .05 , **p < 0.01 ; ns, not significant. One-way ANOVA followed by Tukey’s post-hoc test.
Polyclonal Anti P16 Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+p16/P16-INK4A+Antibody/10__1038_slash_s41419___026___09332___6-304-1-7
Average 96 stars, based on 1 article reviews
polyclonal anti p16 antibody - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

96
Santa Cruz Biotechnology monoclonal anti p16 antibody
Ramelteon inhibits astrocytic senescence and alleviates DA neurodegeneration in MPTP-induced PD mouse model. (A) Representative images of TH immunohistochemical staining in the SNc of mice from the indicated groups. n = 6. Scale bar, 100 μm. (B) Quantification of TH + neuron numbers in the SNc. (C) Rotarod test latency to fall. n = 8. (D) Pole test descending time. n = 8. (E) Immunoblot analysis of <t>p16</t> <t>Ink4a</t> , LaminB1, and β-actin in SNc tissues. n = 3. (F) qRT-PCR analysis of IL-6 , IL-1β , CXCL10 , and MMP9 mRNA levels in the midbrain. n = 3. Data are presented as mean ± SEM. *p < 0 .05 , **p < 0.01 ; ns, not significant. One-way ANOVA followed by Tukey’s post-hoc test.
Monoclonal Anti P16 Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+p16/p16+Antibody/10__1038_slash_s41419___026___09332___6-304-16-22
Average 96 stars, based on 1 article reviews
monoclonal anti p16 antibody - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

96
Proteintech cdkn2a p16 ink4a
Ramelteon inhibits astrocytic senescence and alleviates DA neurodegeneration in MPTP-induced PD mouse model. (A) Representative images of TH immunohistochemical staining in the SNc of mice from the indicated groups. n = 6. Scale bar, 100 μm. (B) Quantification of TH + neuron numbers in the SNc. (C) Rotarod test latency to fall. n = 8. (D) Pole test descending time. n = 8. (E) Immunoblot analysis of <t>p16</t> <t>Ink4a</t> , LaminB1, and β-actin in SNc tissues. n = 3. (F) qRT-PCR analysis of IL-6 , IL-1β , CXCL10 , and MMP9 mRNA levels in the midbrain. n = 3. Data are presented as mean ± SEM. *p < 0 .05 , **p < 0.01 ; ns, not significant. One-way ANOVA followed by Tukey’s post-hoc test.
Cdkn2a P16 Ink4a, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+p16/P16-INK4A+Antibody/pm42884740-55-12-25
Average 96 stars, based on 1 article reviews
cdkn2a p16 ink4a - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

Image Search Results


Immunohistochemical analysis of p16 and p21 in liver tissue. (A, B) Representative immunohistochemistry images of (A) p16 and (B) p21 staining in DBD and DCD liver tissue sections. Scale bars represent 250 μm. (C, D) Quantification of (C) p16‐positive and (D) p21‐positive stained nuclei in DBD and DCD. (E, F) Expression of (E) CDKN2A (p16 INK4a /p19 ARF ) and (F) CDKN1A (p21 CIP1 ) in DBD and DCD, with a higher expression of CDKN2A (p16 INK4a /p19 ARF ) in DCD grafts ( p = 0.229) and an upregulation of CDKN1A (p21 CIP1 ) in DBD grafts ( p < 0.001). DBD; donation after brain death, DCD; donation after circulatory death.

Journal: Aging Cell

Article Title: Transcriptomic Characterization of Cellular Senescence in Human Donor Livers Before Transplantation

doi: 10.1111/acel.70828

Figure Lengend Snippet: Immunohistochemical analysis of p16 and p21 in liver tissue. (A, B) Representative immunohistochemistry images of (A) p16 and (B) p21 staining in DBD and DCD liver tissue sections. Scale bars represent 250 μm. (C, D) Quantification of (C) p16‐positive and (D) p21‐positive stained nuclei in DBD and DCD. (E, F) Expression of (E) CDKN2A (p16 INK4a /p19 ARF ) and (F) CDKN1A (p21 CIP1 ) in DBD and DCD, with a higher expression of CDKN2A (p16 INK4a /p19 ARF ) in DCD grafts ( p = 0.229) and an upregulation of CDKN1A (p21 CIP1 ) in DBD grafts ( p < 0.001). DBD; donation after brain death, DCD; donation after circulatory death.

Article Snippet: Formalin‐fixed paraffin‐embedded tissue sections were cut at 4 μm and stained for p16 (Rabbit anti‐p16 Sc‐1207, Santa Cruz, dilution 1:150) and p21 (Rabbit anti‐p21 Sc‐471, Santa Cruz, dilution 1:400).

Techniques: Immunohistochemical staining, Analysis, Tissue, Immunohistochemistry, Staining, Expressing

Ramelteon inhibits astrocytic senescence and alleviates DA neurodegeneration in MPTP-induced PD mouse model. (A) Representative images of TH immunohistochemical staining in the SNc of mice from the indicated groups. n = 6. Scale bar, 100 μm. (B) Quantification of TH + neuron numbers in the SNc. (C) Rotarod test latency to fall. n = 8. (D) Pole test descending time. n = 8. (E) Immunoblot analysis of p16 Ink4a , LaminB1, and β-actin in SNc tissues. n = 3. (F) qRT-PCR analysis of IL-6 , IL-1β , CXCL10 , and MMP9 mRNA levels in the midbrain. n = 3. Data are presented as mean ± SEM. *p < 0 .05 , **p < 0.01 ; ns, not significant. One-way ANOVA followed by Tukey’s post-hoc test.

Journal: Frontiers in Aging Neuroscience

Article Title: Ramelteon suppresses astrocytic senescence via MT1-cAMP axis to protect dopaminergic neurons

doi: 10.3389/fnagi.2026.1974509

Figure Lengend Snippet: Ramelteon inhibits astrocytic senescence and alleviates DA neurodegeneration in MPTP-induced PD mouse model. (A) Representative images of TH immunohistochemical staining in the SNc of mice from the indicated groups. n = 6. Scale bar, 100 μm. (B) Quantification of TH + neuron numbers in the SNc. (C) Rotarod test latency to fall. n = 8. (D) Pole test descending time. n = 8. (E) Immunoblot analysis of p16 Ink4a , LaminB1, and β-actin in SNc tissues. n = 3. (F) qRT-PCR analysis of IL-6 , IL-1β , CXCL10 , and MMP9 mRNA levels in the midbrain. n = 3. Data are presented as mean ± SEM. *p < 0 .05 , **p < 0.01 ; ns, not significant. One-way ANOVA followed by Tukey’s post-hoc test.

Article Snippet: Primary antibodies used: anti-p16 Ink4a (1:1000, Proteintech, 10,883-1-AP), anti-LaminB1 (1:1000, Proteintech, 12,987-1-AP), anti-β-actin (1:5000, Abcam, ab8226).

Techniques: Immunohistochemical staining, Staining, Rotarod Test, Western Blot, Analysis, Quantitative RT-PCR

Ramelteon suppresses replicative astrocytic senescence in vitro . (A) Representative images of SA-β-gal staining in primary astrocytes cultured for 10 DIV or 40 DIV, treated with or without Ramelteon (50 μM) for 5 days. n = 4. Scale bar, 50 μm. (B) Quantification of SA-β-gal-positive cells. (C) Representative immunofluorescence images of GFAP (red) and LaminB1 (green) in astrocytes from the indicated groups. n = 4. Scale bar, 20 μm. (D) Quantification of LaminB1 fluorescence intensity in GFAP + cells. (E) Immunoblot analysis of p16 Ink4a , LaminB1, and β-actin. n = 3. (F) Quantification of protein levels normalized to β-actin. (G) qRT-PCR analysis of SASP factors ( IL-6 , IL-1β , CXCL10 , and MMP9 ). n = 3. Data are presented as mean ± SEM. **p < 0 .01 . One-way ANOVA followed by Tukey’s post-hoc test.

Journal: Frontiers in Aging Neuroscience

Article Title: Ramelteon suppresses astrocytic senescence via MT1-cAMP axis to protect dopaminergic neurons

doi: 10.3389/fnagi.2026.1974509

Figure Lengend Snippet: Ramelteon suppresses replicative astrocytic senescence in vitro . (A) Representative images of SA-β-gal staining in primary astrocytes cultured for 10 DIV or 40 DIV, treated with or without Ramelteon (50 μM) for 5 days. n = 4. Scale bar, 50 μm. (B) Quantification of SA-β-gal-positive cells. (C) Representative immunofluorescence images of GFAP (red) and LaminB1 (green) in astrocytes from the indicated groups. n = 4. Scale bar, 20 μm. (D) Quantification of LaminB1 fluorescence intensity in GFAP + cells. (E) Immunoblot analysis of p16 Ink4a , LaminB1, and β-actin. n = 3. (F) Quantification of protein levels normalized to β-actin. (G) qRT-PCR analysis of SASP factors ( IL-6 , IL-1β , CXCL10 , and MMP9 ). n = 3. Data are presented as mean ± SEM. **p < 0 .01 . One-way ANOVA followed by Tukey’s post-hoc test.

Article Snippet: Primary antibodies used: anti-p16 Ink4a (1:1000, Proteintech, 10,883-1-AP), anti-LaminB1 (1:1000, Proteintech, 12,987-1-AP), anti-β-actin (1:5000, Abcam, ab8226).

Techniques: In Vitro, Staining, Cell Culture, Immunofluorescence, Fluorescence, Western Blot, Analysis, Quantitative RT-PCR

Ramelteon alleviates MPP + -induced premature astrocytic senescence. ( A) Representative images of SA-β-gal staining in primary astrocytes pretreated with Ramelteon (50 μM) for 2 h followed by MPP + (500 μM) exposure for 24 h. Scale bar, 50 μm. n = 4. (B) Quantification of SA-β-gal-positive cells. (C) Representative immunofluorescence images of GFAP (red) and LaminB1 (green). n = 4. Scale bar, 20 μm. (D) Quantification of LaminB1 fluorescence intensity in GFAP + cells. (E) Immunoblot analysis of p16 Ink4a , LaminB1, and β-actin. n = 3. (F) Quantification of protein levels normalized to β-actin. (G) qRT-PCR analysis of SASP factors ( IL-6 , IL-1β , CXCL10 , and MMP9 ). n = 3. Data are presented as mean ± SEM. *p < 0 .05 , **p < 0.01 . One-way ANOVA followed by Tukey’s post-hoc test.

Journal: Frontiers in Aging Neuroscience

Article Title: Ramelteon suppresses astrocytic senescence via MT1-cAMP axis to protect dopaminergic neurons

doi: 10.3389/fnagi.2026.1974509

Figure Lengend Snippet: Ramelteon alleviates MPP + -induced premature astrocytic senescence. ( A) Representative images of SA-β-gal staining in primary astrocytes pretreated with Ramelteon (50 μM) for 2 h followed by MPP + (500 μM) exposure for 24 h. Scale bar, 50 μm. n = 4. (B) Quantification of SA-β-gal-positive cells. (C) Representative immunofluorescence images of GFAP (red) and LaminB1 (green). n = 4. Scale bar, 20 μm. (D) Quantification of LaminB1 fluorescence intensity in GFAP + cells. (E) Immunoblot analysis of p16 Ink4a , LaminB1, and β-actin. n = 3. (F) Quantification of protein levels normalized to β-actin. (G) qRT-PCR analysis of SASP factors ( IL-6 , IL-1β , CXCL10 , and MMP9 ). n = 3. Data are presented as mean ± SEM. *p < 0 .05 , **p < 0.01 . One-way ANOVA followed by Tukey’s post-hoc test.

Article Snippet: Primary antibodies used: anti-p16 Ink4a (1:1000, Proteintech, 10,883-1-AP), anti-LaminB1 (1:1000, Proteintech, 12,987-1-AP), anti-β-actin (1:5000, Abcam, ab8226).

Techniques: Staining, Immunofluorescence, Fluorescence, Western Blot, Analysis, Quantitative RT-PCR

MT1 is required for the anti-senescence effects of Ramelteon in astrocytes. (A) Immunoblot analysis of p16 Ink4a , LaminB1, and β-actin in 40 DIV astrocytes transfected with si- Control or si- Mtnr1a and treated with Ramelteon (50 μM) for 5 days. (B) Quantification of protein levels normalized to β-actin. (C) Immunoblot analysis of p16 Ink4a , LaminB1, and β-actin in MPP + -treated astrocytes transfected with si- Control or si- Mtnr1a . n = 3. (D) Quantification of protein levels normalized to β -actin. (E) Immunoblot analysis of p16 Ink4a , LaminB1, and β -actin in 40 DIV astrocytes transfected with si- Control or si- Mtnr1b . (F) Quantification of protein levels normalized to β -actin. (G) Immunoblot analysis of p 16Ink4a , LaminB1, and β -actin in MPP + -treated astrocytes transfected with si- Control or si- Mtnr1b . (H) Quantification of protein levels normalized to β -actin. Data are presented as mean ± SEM. n = 3. *p < 0 .05 , **p < 0.01 ; ns, not significant. One-way ANOVA followed by Tukey’s post-hoc test.

Journal: Frontiers in Aging Neuroscience

Article Title: Ramelteon suppresses astrocytic senescence via MT1-cAMP axis to protect dopaminergic neurons

doi: 10.3389/fnagi.2026.1974509

Figure Lengend Snippet: MT1 is required for the anti-senescence effects of Ramelteon in astrocytes. (A) Immunoblot analysis of p16 Ink4a , LaminB1, and β-actin in 40 DIV astrocytes transfected with si- Control or si- Mtnr1a and treated with Ramelteon (50 μM) for 5 days. (B) Quantification of protein levels normalized to β-actin. (C) Immunoblot analysis of p16 Ink4a , LaminB1, and β-actin in MPP + -treated astrocytes transfected with si- Control or si- Mtnr1a . n = 3. (D) Quantification of protein levels normalized to β -actin. (E) Immunoblot analysis of p16 Ink4a , LaminB1, and β -actin in 40 DIV astrocytes transfected with si- Control or si- Mtnr1b . (F) Quantification of protein levels normalized to β -actin. (G) Immunoblot analysis of p 16Ink4a , LaminB1, and β -actin in MPP + -treated astrocytes transfected with si- Control or si- Mtnr1b . (H) Quantification of protein levels normalized to β -actin. Data are presented as mean ± SEM. n = 3. *p < 0 .05 , **p < 0.01 ; ns, not significant. One-way ANOVA followed by Tukey’s post-hoc test.

Article Snippet: Primary antibodies used: anti-p16 Ink4a (1:1000, Proteintech, 10,883-1-AP), anti-LaminB1 (1:1000, Proteintech, 12,987-1-AP), anti-β-actin (1:5000, Abcam, ab8226).

Techniques: Western Blot, Analysis, Transfection, Control

cAMP reduction contributes to Ramelteon-induced suppression of astrocytic senescence. (A) Intracellular cAMP levels in 10 DIV and 40 DIV astrocytes treated with or without Ramelteon (50 μM) for 5 days. n = 4. (B) Intracellular cAMP levels in astrocytes treated with MPP + (500 μM) in the presence or absence of Ramelteon (50 μM). n = 4. (C) Immunoblot analysis of p16 Ink4a , LaminB1, and β -actin in 40 DIV astrocytes treated with Ramelteon and/or SQ22536 (50 μM) or dbcAMP (1 mM). n = 3. (D) Quantification of protein levels normalized to β-actin. (E) Immunoblot analysis of p16 Ink4a , LaminB1, and β -actin in MPP + -treated astrocytes with Ramelteon and/or SQ22536 (50 μM) or dbcAMP (1 mM). n = 3. (F) Quantification of protein levels normalized to β-actin. * p < 0 .05 , **p < 0 .01 . One-way ANOVA followed by Tukey’s post-hoc test.

Journal: Frontiers in Aging Neuroscience

Article Title: Ramelteon suppresses astrocytic senescence via MT1-cAMP axis to protect dopaminergic neurons

doi: 10.3389/fnagi.2026.1974509

Figure Lengend Snippet: cAMP reduction contributes to Ramelteon-induced suppression of astrocytic senescence. (A) Intracellular cAMP levels in 10 DIV and 40 DIV astrocytes treated with or without Ramelteon (50 μM) for 5 days. n = 4. (B) Intracellular cAMP levels in astrocytes treated with MPP + (500 μM) in the presence or absence of Ramelteon (50 μM). n = 4. (C) Immunoblot analysis of p16 Ink4a , LaminB1, and β -actin in 40 DIV astrocytes treated with Ramelteon and/or SQ22536 (50 μM) or dbcAMP (1 mM). n = 3. (D) Quantification of protein levels normalized to β-actin. (E) Immunoblot analysis of p16 Ink4a , LaminB1, and β -actin in MPP + -treated astrocytes with Ramelteon and/or SQ22536 (50 μM) or dbcAMP (1 mM). n = 3. (F) Quantification of protein levels normalized to β-actin. * p < 0 .05 , **p < 0 .01 . One-way ANOVA followed by Tukey’s post-hoc test.

Article Snippet: Primary antibodies used: anti-p16 Ink4a (1:1000, Proteintech, 10,883-1-AP), anti-LaminB1 (1:1000, Proteintech, 12,987-1-AP), anti-β-actin (1:5000, Abcam, ab8226).

Techniques: Western Blot, Analysis

Schematic diagram illustrating the proposed mechanism by which Ramelteon suppresses astrocytic senescence and protects dopaminergic neurons. Ramelteon activates MT1 receptor coupled to Gα i protein, which inhibits adenylate cyclase (AC) and reduces intracellular cAMP levels. The suppression of cAMP leads to decreased mitochondrial ROS production. This signaling cascade attenuates astrocytic senescence, as evidenced by reduced p16 Ink4a expression and SASP factor release, and ultimately protects dopaminergic neurons from degeneration. Created with BioRender.com .

Journal: Frontiers in Aging Neuroscience

Article Title: Ramelteon suppresses astrocytic senescence via MT1-cAMP axis to protect dopaminergic neurons

doi: 10.3389/fnagi.2026.1974509

Figure Lengend Snippet: Schematic diagram illustrating the proposed mechanism by which Ramelteon suppresses astrocytic senescence and protects dopaminergic neurons. Ramelteon activates MT1 receptor coupled to Gα i protein, which inhibits adenylate cyclase (AC) and reduces intracellular cAMP levels. The suppression of cAMP leads to decreased mitochondrial ROS production. This signaling cascade attenuates astrocytic senescence, as evidenced by reduced p16 Ink4a expression and SASP factor release, and ultimately protects dopaminergic neurons from degeneration. Created with BioRender.com .

Article Snippet: Primary antibodies used: anti-p16 Ink4a (1:1000, Proteintech, 10,883-1-AP), anti-LaminB1 (1:1000, Proteintech, 12,987-1-AP), anti-β-actin (1:5000, Abcam, ab8226).

Techniques: Expressing